Your browser doesn't support javascript.
loading
Biochemical and biophysical characterization of purified native CD20 alone and in complex with rituximab and obinutuzumab.
Agez, Morgane; Mandon, Elodie Desuzinges; Iwema, Thomas; Gianotti, Reto; Limani, Florian; Herter, Sylvia; Mössner, Ekkehard; Kusznir, Eric A; Huber, Sylwia; Lauer, Matthias; Ringler, Philippe; Ferrara, Claudia; Klein, Christian; Jawhari, Anass.
Afiliação
  • Agez M; CALIXAR, 60 avenue Rockefeller 69008, Lyon, France.
  • Mandon ED; CALIXAR, 60 avenue Rockefeller 69008, Lyon, France.
  • Iwema T; CALIXAR, 60 avenue Rockefeller 69008, Lyon, France.
  • Gianotti R; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland.
  • Limani F; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland.
  • Herter S; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland.
  • Mössner E; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland.
  • Kusznir EA; Roche Pharma Research and Early Development, Lead Discovery, Roche Innovation Center Basel, Basel, Switzerland.
  • Huber S; Roche Pharma Research and Early Development, Lead Discovery, Roche Innovation Center Basel, Basel, Switzerland.
  • Lauer M; Roche Pharma Research and Early Development, Lead Discovery, Roche Innovation Center Basel, Basel, Switzerland.
  • Ringler P; Center for Cellular Imaging and NanoAnalytics (C-CINA), Biozentrum, University of Basel, Basel, Switzerland.
  • Ferrara C; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland.
  • Klein C; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland.
  • Jawhari A; CALIXAR, 60 avenue Rockefeller 69008, Lyon, France. ajawhari@calixar.com.
Sci Rep ; 9(1): 13675, 2019 09 23.
Article em En | MEDLINE | ID: mdl-31548565

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Antígenos CD20 / Anticorpos Monoclonais Humanizados / Rituximab Limite: Humans Idioma: En Revista: Sci Rep Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Antígenos CD20 / Anticorpos Monoclonais Humanizados / Rituximab Limite: Humans Idioma: En Revista: Sci Rep Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França